Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{ 1-hydroxy-1-methyl-ethyl} pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl} -1h-benzimidazol-2-yl]urea

摘要

The disclosure relates to solid forms of compound of formula (I) and pharmaceutically acceptable salts thereof, particularly the hydrochloride salt and the solid amorphous mesylate salt, that inhibit bacterial enzymes gyrase and/or topoisomerase IV. Also disclosed are pharmaceutical compositions comprising said compound of formula (I) or its salts and their use for treating bacterial infection.